Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 12 04:00PM ET
1.11
Dollar change
-0.07
Percentage change
-5.93
%
Index- P/E- EPS (ttm)-0.91 Insider Own3.41% Shs Outstand37.94M Perf Week-7.11%
Market Cap42.12M Forward P/E- EPS next Y-0.12 Insider Trans1.57% Shs Float36.66M Perf Month-17.16%
Income-36.44M PEG- EPS next Q-0.15 Inst Own44.06% Short Float2.17% Perf Quarter-23.97%
Sales8.57M P/S4.92 EPS this Y-145.47% Inst Trans87.28% Short Ratio5.33 Perf Half Y-47.89%
Book/sh1.54 P/B0.72 EPS next Y81.01% ROA-29.44% Short Interest0.80M Perf Year-31.90%
Cash/sh1.83 P/C0.61 EPS next 5Y- ROE-48.42% 52W Range1.15 - 3.07 Perf YTD-50.22%
Dividend Est.- P/FCF- EPS past 5Y- ROI-59.92% 52W High-63.84% Beta1.52
Dividend TTM- Quick Ratio3.13 Sales past 5Y487.70% Gross Margin1445.55% 52W Low-3.48% ATR (14)0.07
Dividend Ex-Date- Current Ratio3.13 EPS Y/Y TTM-163.86% Oper. Margin-608.57% RSI (14)32.76 Volatility5.85% 6.16%
Employees29 Debt/Eq0.27 Sales Y/Y TTM-93.70% Profit Margin-425.41% Recom1.00 Target Price6.88
Option/ShortYes / Yes LT Debt/Eq0.04 EPS Q/Q-57.49% Payout0.00% Rel Volume2.47 Prev Close1.18
Sales Surprise-89.32% EPS Surprise58.13% Sales Q/Q-62.52% EarningsNov 06 AMC Avg Volume149.20K Price1.11
SMA20-9.92% SMA50-17.77% SMA200-34.16% Trades Volume368,344 Change-5.93%
Date Action Analyst Rating Change Price Target Change
Jan-22-21Initiated Guggenheim Buy $25
Jan-06-21Initiated Cantor Fitzgerald Overweight $30
Jul-11-18Upgrade Needham Hold → Buy $5
Jun-27-18Initiated Maxim Group Buy $6
Oct-24-17Initiated Guggenheim Buy $6
Jul-10-17Initiated ROTH Capital Buy $8.50
May-09-17Downgrade Needham Buy → Hold
Mar-03-17Reiterated RBC Capital Mkts Outperform $15 → $11
Oct-20-16Initiated H.C. Wainwright Buy $14
Oct-07-16Upgrade WBB Securities Buy → Strong Buy $8
Nov-06-24 05:55PM
04:30PM
Oct-10-24 08:00AM
Oct-07-24 05:02PM
Oct-03-24 08:00AM
08:00AM Loading…
Aug-27-24 08:00AM
Aug-08-24 05:44PM
04:30PM
Jul-23-24 07:00AM
Jul-22-24 06:24AM
Jul-11-24 07:00AM
Jul-01-24 02:18PM
May-31-24 11:50AM
May-23-24 06:42AM
May-08-24 11:54PM
04:51PM Loading…
04:51PM
04:30PM
Apr-30-24 04:05PM
Apr-16-24 11:52AM
Apr-09-24 04:05PM
Mar-28-24 11:53PM
04:01PM
Jan-30-24 04:05PM
Jan-29-24 05:15PM
Jan-05-24 08:30AM
Dec-27-23 09:30AM
Nov-27-23 10:33AM
Nov-15-23 01:15PM
Nov-13-23 05:55PM
05:17PM
08:00AM Loading…
Oct-24-23 08:00AM
Oct-18-23 09:00PM
Oct-16-23 08:00AM
Oct-02-23 09:00PM
Sep-27-23 08:31PM
07:49AM
Sep-25-23 08:55AM
Sep-20-23 04:00AM
Sep-04-23 01:31PM
Aug-28-23 10:17PM
08:00AM
Aug-14-23 04:59PM
04:30PM
Aug-11-23 09:09AM
Jul-20-23 09:58AM
Jun-26-23 02:20PM
07:00AM
Jun-21-23 07:00AM
Jun-15-23 04:10PM
May-19-23 09:22AM
May-12-23 08:00AM
May-11-23 08:45AM
07:37AM
07:00AM
May-08-23 03:38PM
Apr-13-23 08:30AM
Apr-11-23 01:33PM
Mar-31-23 12:31PM
08:30AM
Mar-30-23 01:12PM
09:36AM
07:05AM
Mar-22-23 09:25AM
07:06AM
Mar-01-23 04:03PM
Jan-14-23 07:43AM
Dec-01-22 08:00AM
Nov-30-22 08:30AM
Nov-17-22 08:30AM
Nov-11-22 05:37AM
Nov-09-22 08:15AM
07:00AM
Nov-07-22 08:30AM
Nov-03-22 08:30AM
Nov-02-22 10:01AM
Nov-01-22 08:30AM
Oct-25-22 08:30AM
Oct-24-22 08:30AM
Oct-20-22 07:00AM
Oct-11-22 08:30AM
Oct-07-22 09:25AM
Sep-09-22 08:30AM
Sep-08-22 08:30AM
Sep-01-22 08:30AM
Aug-15-22 08:15AM
07:00AM
Aug-09-22 08:30AM
Aug-04-22 08:30AM
Aug-01-22 08:30AM
Jul-19-22 08:30AM
Jul-14-22 08:30AM
Jun-29-22 07:06AM
Jun-23-22 08:30AM
Jun-08-22 08:30AM
Jun-03-22 04:05PM
May-20-22 08:30AM
May-12-22 08:35AM
07:00AM
May-10-22 08:30AM
May-05-22 08:30AM
SCYNEXIS, Inc. is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J. Outcalt, and Yves Joseph Ribeill on November 4, 1999 and is headquartered in Jersey City, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Federated Hermes Kaufmann Fund10% OwnerDec 11 '24Proposed Sale1.2310,98813,515Dec 11 03:57 PM
Federated Hermes Kaufmann Smal10% OwnerDec 11 '24Proposed Sale1.23300,899370,106Dec 11 03:41 PM
Federated Hermes Kaufmann Fund10% OwnerDec 11 '24Proposed Sale1.23388,113477,379Dec 11 03:40 PM
Angulo Gonzalez DavidChief Executive OfficerSep 12 '24Buy1.3720,00027,400507,871Sep 16 08:00 AM
Federated Hermes Kaufmann Fund10% OwnerAug 22 '24Proposed Sale1.779,70017,169Aug 27 05:30 PM
Federated Hermes Kaufmann Smal10% OwnerAug 22 '24Proposed Sale1.77272,000481,440Aug 27 05:29 PM
Federated Hermes Kaufmann Fund10% OwnerAug 22 '24Proposed Sale1.77338,000598,260Aug 27 05:28 PM
Federated Hermes Kaufmann Fund10% OwnerAug 22 '24Proposed Sale1.779,70017,169Aug 22 04:49 PM
Federated Hermes Kaufmann Smal10% OwnerAug 22 '24Proposed Sale1.77272,000481,440Aug 22 04:48 PM
Federated Hermes Kaufmann Fund10% OwnerAug 22 '24Proposed Sale1.77338,000598,260Aug 22 04:48 PM